-
公开(公告)号:US07736393B2
公开(公告)日:2010-06-15
申请号:US11578971
申请日:2005-04-18
IPC分类号: A61F2/02 , A61F2/00 , A61B17/00 , A61L15/10 , C08G63/91 , C08G65/332 , C08G63/08 , C08L67/04
CPC分类号: A61L27/58 , A61L27/18 , A61L2430/32 , Y10S623/926 , C08L67/04
摘要: Provided are an artificial dura mater having a laminated constitution of at least two layers of in vivo degradable polymers, at least one layer of them being a substrate layer, the substrate layer being formed of a lactic acid/glycolic acid/ε-caprolactone copolymer, the copolymer having a component molar ratio of 60-85:3-15:10-30 mol % and the copolymer having an average chain length that satisfies the following expressions (1) to (3) and a process for the production thereof, and when this artificial dura mater is used, no liquid leakage is caused since the bloating of suture holes is small, and the period of time for which it retains its strength is suitably a little longer than the period of time required for the regeneration of an autodura mater, 2
摘要翻译: 本发明提供一种具有至少两层体内可降解聚合物的层压结构的人造硬膜,其至少一层为基材层,所述基材层由乳酸/乙醇酸/己内酯共聚物 ,共聚物的组分摩尔比为60-85:3-15:10-30摩尔%,共聚物的平均链长满足下述表达式(1)至(3)及其制备方法, 当使用这种人造硬膜时,由于缝合孔的膨胀小而导致液体泄漏,并且其保持其强度的时间段适宜地比再生的时间长一点 自然硬度,2
-
公开(公告)号:US20070233275A1
公开(公告)日:2007-10-04
申请号:US11578971
申请日:2005-04-18
IPC分类号: A61F2/02
CPC分类号: A61L27/58 , A61L27/18 , A61L2430/32 , Y10S623/926 , C08L67/04
摘要: Provided are an artificial dura mater having a laminated constitution of at least two layers of in vivo degradable polymers, at least one layer of them being a substrate layer, the substrate layer being formed of a lactic acid/glycolic acid/ε-caprolactone copolymer, the copolymer having a component molar ratio of 60-85:3-15:10-30 mol % and the copolymer having an average chain length that satisfies the following expressions (1) to (3) and a process for the production thereof, and when this artificial dura mater is used, no liquid leakage is caused since the bloating of suture holes is small, and the period of time for which it retains its strength is suitably a little longer than the period of time required for the regeneration of an autodura mater, 2
摘要翻译: 本发明提供一种人造硬膜,其具有至少两层体内可降解聚合物的层叠结构,其至少一层为基材层,所述基材层由乳酸/乙醇酸/ε-己内酯共聚物形成, 所述共聚物的组分摩尔比为60-85:3-15:10-30摩尔%,所述共聚物的平均链长满足下述表达式(1)至(3)及其制备方法, 当使用这种人造硬脑膜时,不会引起液体渗漏,因为缝合孔的膨胀小,并且其保持其强度的时间段适宜地比自动切口再生所需的时间长一点 2,
<?in-line-formula description =“In-line formula”end =“lead”?> 1 < L(GA)<[GA%/(LA%+ GA%+ CL%)] xXx0。 58(2)<?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-line Formulas”end =“lead”?> 1 < L(CL)<[CL%/(LA%+ GA%+ CL%)xXx0。 其中L(LA),L(GA)和L(CL)表示乳酸单元的平均链长,58(3)<? 乙醇酸单元和己内酯单元,LA%,GA%和CL%表示共聚物中乳酸组分,乙醇酸组分己内酯组分的摩尔比,X是共聚物的聚合度。 -
公开(公告)号:US20060246139A1
公开(公告)日:2006-11-02
申请号:US11411193
申请日:2006-04-25
申请人: Tatsuaki Miyaji , Makoto Sato , Tamaki Murayama , Yohei Hoashi , Hisae Saito , Takao Okada , Yukari Imamura , Yoshimichi Fujiyama
发明人: Tatsuaki Miyaji , Makoto Sato , Tamaki Murayama , Yohei Hoashi , Hisae Saito , Takao Okada , Yukari Imamura , Yoshimichi Fujiyama
CPC分类号: A61K9/0024 , A61K9/1647 , A61K38/09 , Y10S514/80 , Y10S514/964
摘要: A bioabsorbable release-sustaining pharmaceutical formulation using a biodegradable release-sustaining base material which can prevent an effective component drug from being released too rapidly just after administration of the formulation and then allow continued release of the drug for at least one month at a defined rate, is provided. For the biodegradable release-sustaining base material, a lactic acid-glycolic acid copolymer (PLGA) with an adjusted distribution in molecular weight is used.
摘要翻译: 使用可生物降解的释放维持基质的生物可吸收释放的释放性药物制剂,其可以在施用制剂后防止有效成分药物过快释放,然后允许药物以规定的速率持续释放至少一个月 ,被提供。 对于可生物降解的释放维持基材,使用调节分子量分布的乳酸 - 乙醇酸共聚物(PLGA)。
-
公开(公告)号:US07342048B2
公开(公告)日:2008-03-11
申请号:US11411193
申请日:2006-04-25
申请人: Tatsuaki Miyaji , Makoto Sato , Tamaki Murayama , Yohei Hoashi , Hisae Saito , Takao Okada , Yukari Imamura , Yoshimichi Fujiyama
发明人: Tatsuaki Miyaji , Makoto Sato , Tamaki Murayama , Yohei Hoashi , Hisae Saito , Takao Okada , Yukari Imamura , Yoshimichi Fujiyama
CPC分类号: A61K9/0024 , A61K9/1647 , A61K38/09 , Y10S514/80 , Y10S514/964
摘要: A bioabsorbable release-sustaining pharmaceutical formulation using a biodegradable release-sustaining base material which can prevent an effective component drug from being released too rapidly just after administration of the formulation and then allow continued release of the drug for at least one month at a defined rate, is provided. For the biodegradable release-sustaining base material, a lactic acid-glycolic acid copolymer (PLGA) with an adjusted distribution in molecular weight is used.
摘要翻译: 使用可生物降解的释放维持基质的生物可吸收释放的释放性药物制剂,其可以在施用制剂后防止有效成分药物过快释放,然后允许药物以规定的速率持续释放至少一个月 ,被提供。 对于可生物降解的释放维持基材,使用调节分子量分布的乳酸 - 乙醇酸共聚物(PLGA)。
-
公开(公告)号:US06441073B1
公开(公告)日:2002-08-27
申请号:US09807707
申请日:2001-04-17
申请人: Junzo Tanaka , Masanori Kikuchi , Kimihiro Miyamoto , Shuji Suwa , Shunji Ichikawa , Etsuro Yokoyama , Soichi Shono , Takao Okada , Yukari Imamura , Kazuo Takakuda , Yoshihisa Koyama , Shigeo Tanaka , Noriaki Shirahama , Takatoshi Itoh
发明人: Junzo Tanaka , Masanori Kikuchi , Kimihiro Miyamoto , Shuji Suwa , Shunji Ichikawa , Etsuro Yokoyama , Soichi Shono , Takao Okada , Yukari Imamura , Kazuo Takakuda , Yoshihisa Koyama , Shigeo Tanaka , Noriaki Shirahama , Takatoshi Itoh
IPC分类号: C08K332
CPC分类号: A61L31/127 , A61L27/46 , A61L27/58 , A61L27/54 , A61L27/507 , C08L67/04 , A61L31/18 , A61L31/16
摘要: The followings are disclosed herein: a biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone; a biomaterial for the induction of osteoanagenesis, characterized in that a periosteum is attached to the biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone; and a biomaterial for the prevention of adhesion comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone where the molar ratio of lactic acid, glycolic acid and &egr;-caprolactone is within a range of 5-90:3-75:5-40.
摘要翻译: 本文公开了以下内容:包含磷酸钙和乳酸,乙醇酸和ε-己内酯的共聚物的生物材料;用于诱导骨诱导成骨的生物材料,其特征在于,将骨膜连接到包含磷酸钙的生物材料和 乳酸,乙醇酸和ε-己内酯; 以及乳酸,乙醇酸和ε-己内酯的摩尔比在5-90:3〜75的范围内的防止粘附性的生物材料,包括磷酸钙和乳酸,乙醇酸和ε-己内酯的共聚物 :5-40。
-
公开(公告)号:US6140007A
公开(公告)日:2000-10-31
申请号:US214154
申请日:1999-05-12
IPC分类号: G03F7/004 , C08F2/50 , C08L33/26 , C08L39/06 , C09D4/00 , C09D5/00 , G02B5/20 , G03F7/00 , G03F7/008 , G03F7/012 , G03F7/033 , G03F7/038 , H01J9/227 , G03F7/12 , G03F7/30
CPC分类号: G03F7/0007 , G03F7/0125
摘要: Photosensitive compositions prepared without use of a chromium compound. The compositions exhibit high resolution and satisfactory sensitivity, and do not cause environmental pollution. The photosensitive compositions contain a water-soluble azide compound which serves as a photocrosslinking agent and poly(N-vinylformamide) that is photocrosslinkable in the presence of the water-soluble azide compound.
摘要翻译: PCT No.PCT / JP98 / 01926 Sec。 371日期1999年5月12日 102(e)日期1999年5月12日PCT提交1998年4月27日PCT公布。 WO98 / 49600 PCT出版物 日期1998年11月5日不使用铬化合物制备的感光组合物。 该组合物表现出高分辨率和令人满意的敏感性,不会造成环境污染。 光敏组合物含有作为光交联剂的水溶性叠氮化合物和在水溶性叠氮化合物存在下可光交联的聚(N-乙烯基甲酰胺)。
-
-
-
-
-